Publications by authors named "Inmaculada Roldan"

Claim this Profile
Q
Quality of anticoagulation with vitamin K antagonists in Spain: A systematic review with meta-analysis of national registries.
José Miguel Rivera-Caravaca, Danilo Menichelli, Daniele Pastori, Eva Soler-Espejo, María Asunción Esteve-Pastor

Med Clin (Barc)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Impact of antithrombotic treatment and geriatric syndromes in octogenarians with atrial fibrillation and ischaemic heart disease. Atrial Fibrillation and Ischemic Heart Disease in the Elderly].
Clara Bonanad Lozano, Pablo Díez-Villanueva, Sergio García Blas, Ana Ayesta, Sonia Ibars

Rev Esp Geriatr Gerontol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology].
David Vivas, Vanessa Roldán, María Asunción Esteve-Pastor, Inmaculada Roldán, Antonio Tello-Montoliu

Rev Esp Cardiol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology.
David Vivas, Vanessa Roldán, María Asunción Esteve-Pastor, Inmaculada Roldán, Antonio Tello-Montoliu

Rev Esp Cardiol (Engl Ed)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a "Real-world" Nationwide Registry: Insights From the FANTASIIA Study.
Martín Ruiz Ortiz, Javier Muñiz, María Asunción Esteve-Pastor, Francisco Marín, Inmaculada Roldán

J Cardiovasc Pharmacol Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of inappropriate doses of direct oral anticoagulants in clinical practice.
Martín Ruiz Ortiz, María Asunción Esteve-Pastor, Inmaculada Roldán, Javier Muñiz, Francisco Marín

Rev Esp Cardiol (Engl Ed)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High and low on-treatment platelet reactivity to P2Y inhibitors in a contemporary cohort of acute coronary syndrome patients undergoing percutaneous coronary intervention.
José Luis Ferreiro, David Vivas, Jesús María De La Hera, Ana Lucrecia Marcano, Leslie Marisol Lugo

Thromb Res· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry.
Martín Ruiz Ortiz, Javier Muñiz, Paula Raña Míguez, Inmaculada Roldán, Francisco Marín

Europace· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic Therapy and Surgery: From Consensus to Clinical Practice. Response to Related Letters.
David Vivas, Jose Luis Ferreiro, Inmaculada Roldán

Rev Esp Cardiol (Engl Ed)· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU.
David Vivas, Inmaculada Roldán, Raquel Ferrandis, Francisco Marín, Vanessa Roldán

Rev Esp Cardiol (Engl Ed)· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comments on the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease.

Rev Esp Cardiol (Engl Ed)· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comments on the 2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-segment Elevation.

Rev Esp Cardiol (Engl Ed)· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comments on the 2016 ESC Guidelines for the Management of Atrial Fibrillation.
F Arribas, , Fernando Arribas, Inmaculada Roldán, José Luis Merino

Rev Esp Cardiol (Engl Ed)· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation.
Carme Pinyol, Jose Mª Cepeda, Inmaculada Roldan, Vanesa Roldan, Silvia Jimenez

Cardiol Ther· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral anticoagulation in octogenarians with atrial fibrillation.
González Saldivar Hugo, Lourdes M Figueiras-Graillet, Manuel Anguita, Francisco Marín, Vicente Bertomeu

Int J Cardiol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural Heart Disease in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Prevalence and Clinical Profile in a Spanish Sample.
Martín Ruiz Ortiz, Inmaculada Roldán, Vicente Bertomeu, Javier Muñiz, Francisco Marín

Rev Esp Cardiol (Engl Ed)· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?
María Asunción Esteve-Pastor, Amaya García-Fernández, Manuel Macías, Francisco Sogorb, Mariano Valdés

Circ J· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the Way to a Better Use of Anticoagulants in Nonvalvular Atrial Fibrillation. Proposed Amendment to the Therapeutic Positioning Report UT/V4/23122013.
Inmaculada Roldán, Francisco Marín, , ,

Rev Esp Cardiol (Engl Ed)· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study.
José Moreno-Arribas, Vicente Bertomeu-González, Manuel Anguita-Sanchez, Ángel Cequier, Javier Muñiz

J Cardiovasc Pharmacol Ther· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Satisfaction with medical care in patients with atrial fibrillation treated with vitamin K antagonists versus new oral anticoagulants.
Manuel Anguita, Francisco Marín, Inmaculada Roldán, Angel Cequier, Vicente Bertomeu

Rev Esp Cardiol (Engl Ed)· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Anticoagulation With Vitamin K Antagonists.
Vicente Bertomeu-González, Manuel Anguita, José Moreno-Arribas, Ángel Cequier, Javier Muñiz

Clin Cardiol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comments on the ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology.

Rev Esp Cardiol (Engl Ed)· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Reduction of haemorrhagic risk in acute coronary syndromes].
Alvaro Merino, Inmaculada Roldán, Francisco Marín, Fernando Worner,

Med Clin (Barc)· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Clinical characteristics, prognosis, and variability in the management of non-ST-segment elevation acute coronary syndromes. Data from the PEPA registry].
Xavier Bosch, Esteban López De Sá, José López Sendón, Jaime Aboal, Faustino Miranda-Guardiola

Rev Esp Cardiol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis